Robert Susman

Insider Reports History

Location
New York, NY
Signature
/s/ Christopher Van Tuyl, Attorney-in-Fact for Robert Susman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Susman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Director Common Stock 25,016 $367,234 $14.68 01 May 2025 Direct
Immunovant, Inc. Director Stock Option (Right to Buy) 35,234 01 May 2025 Direct

Insider Reports Filed by Robert Susman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMVT Immunovant, Inc. 01 May 2025 2 $0 4 Director 05 May 2025, 19:30
IMVT Immunovant, Inc. 18 Apr 2025 0 $0 3 Director 28 Apr 2025, 17:01